In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Solid Biosciences Inc (NASDAQ: SLDB) closed at $6.29 up 1.62% from its previous closing price of $6.19. In other words, the price has increased by $1.62 from its previous closing price. On the day, 1.13 million shares were traded. SLDB stock price reached its highest trading level at $6.53 during the session, while it also had its lowest trading level at $6.2.
Ratios:
For a deeper understanding of Solid Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.89 and its Current Ratio is at 10.89. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on June 26, 2025, initiated with a Buy rating and assigned the stock a target price of $14.
On January 08, 2025, Truist started tracking the stock assigning a Buy rating and target price of $16.
On December 13, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $16.Wedbush initiated its Outperform rating on December 13, 2024, with a $16 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 11 ’25 when Kahn Clare bought 1,860 shares for $5.34 per share. The transaction valued at 9,924 led to the insider holds 2,960 shares of the business.
Bain Capital Life Sciences Inv bought 1,000,000 shares of SLDB for $4,030,000 on Feb 19 ’25. The 10% Owner now owns 5,034,582 shares after completing the transaction at $4.03 per share. On Feb 19 ’25, another insider, PERCEPTIVE ADVISORS LLC, who serves as the Director of the company, bought 5,000,000 shares for $4.03 each. As a result, the insider paid 20,150,000 and bolstered with 11,833,539 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLDB now has a Market Capitalization of 487571872 and an Enterprise Value of 204279728.
Stock Price History:
The Beta on a monthly basis for SLDB is 2.57, which has changed by -0.12150836 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, SLDB has reached a high of $10.37, while it has fallen to a 52-week low of $2.41. The 50-Day Moving Average of the stock is 17.90%, while the 200-Day Moving Average is calculated to be 38.95%.
Shares Statistics:
For the past three months, SLDB has traded an average of 1.70M shares per day and 1204420 over the past ten days. A total of 77.49M shares are outstanding, with a floating share count of 56.53M. Insiders hold about 27.07% of the company’s shares, while institutions hold 78.83% stake in the company. Shares short for SLDB as of 1752537600 were 10231952 with a Short Ratio of 6.01, compared to 1749772800 on 8076349. Therefore, it implies a Short% of Shares Outstanding of 10231952 and a Short% of Float of 15.7.
Earnings Estimates
As of right now, 11.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.5, with high estimates of -$0.43 and low estimates of -$0.6.
Analysts are recommending an EPS of between -$1.82 and -$2.83 for the fiscal current year, implying an average EPS of -$2.19. EPS for the following year is -$2.14, with 10.0 analysts recommending between -$1.39 and -$2.68.
